Characterizing barriers to care in patients with hidradenitis suppurativa

Authors

  • Josiah Williams Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, NC, USA Author
  • Veronica Emmerich Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, NC, USA Author
  • Emily Moya Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, NC, USA Author
  • Anita Rong Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, NC, USA Author
  • Steven Feldman Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, NC, USA Author
  • Rita Pichardo Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, NC, USA Author

DOI:

https://doi.org/10.25251/zv612447

Keywords:

barriers to care, diagnostic delay, healthcare costs, healthcare disparities, hidradenitis suppurativa, socioeconomic status

References

1. Nguyen TV, Damiani G, Orenstein LAV, et al. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol. 2021;35(1):50-61. [PMID: 32460374].

2. Rick JW, Thompson AM, Fernandez JM, et al. Misdiagnoses and barriers to care in hidradenitis suppurativa: A patient survey. Australas J Dermatol. 2021. [PMID: 34314017].

3. Saunte DM, Boer J, Stratigos A, et al. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol. 2015;173(6):1546-1549. [PMID: 26198191].

4. Marvel J, Vlahiotis A, Sainski-Nguyen A, et al. Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data. BMJ open. 2019;9(9):e030579. [PMID: 31575575].

Downloads

Published

01/05/2026